1. Home
  2. STXS vs MYO Comparison

STXS vs MYO Comparison

Compare STXS & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • MYO
  • Stock Information
  • Founded
  • STXS 1990
  • MYO 2004
  • Country
  • STXS United States
  • MYO United States
  • Employees
  • STXS N/A
  • MYO N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MYO Industrial Specialties
  • Sector
  • STXS Health Care
  • MYO Health Care
  • Exchange
  • STXS Nasdaq
  • MYO Nasdaq
  • Market Cap
  • STXS 151.3M
  • MYO 153.0M
  • IPO Year
  • STXS 2004
  • MYO 2017
  • Fundamental
  • Price
  • STXS $2.13
  • MYO $2.44
  • Analyst Decision
  • STXS
  • MYO Strong Buy
  • Analyst Count
  • STXS 0
  • MYO 4
  • Target Price
  • STXS N/A
  • MYO $9.63
  • AVG Volume (30 Days)
  • STXS 207.9K
  • MYO 531.3K
  • Earning Date
  • STXS 08-11-2025
  • MYO 08-05-2025
  • Dividend Yield
  • STXS N/A
  • MYO N/A
  • EPS Growth
  • STXS N/A
  • MYO N/A
  • EPS
  • STXS N/A
  • MYO N/A
  • Revenue
  • STXS $27,510,000.00
  • MYO $38,628,624.00
  • Revenue This Year
  • STXS $25.90
  • MYO $55.29
  • Revenue Next Year
  • STXS $60.57
  • MYO $27.18
  • P/E Ratio
  • STXS N/A
  • MYO N/A
  • Revenue Growth
  • STXS 1.50
  • MYO 97.60
  • 52 Week Low
  • STXS $1.54
  • MYO $2.35
  • 52 Week High
  • STXS $2.72
  • MYO $7.17
  • Technical
  • Relative Strength Index (RSI)
  • STXS 47.58
  • MYO 20.55
  • Support Level
  • STXS $2.06
  • MYO $2.70
  • Resistance Level
  • STXS $2.36
  • MYO $2.89
  • Average True Range (ATR)
  • STXS 0.11
  • MYO 0.15
  • MACD
  • STXS -0.01
  • MYO 0.01
  • Stochastic Oscillator
  • STXS 19.70
  • MYO 12.93

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Share on Social Networks: